Remove roche-touts-near-complete-suppression-multiple-sclerosis-relapse-injectable-ocrevus
article thumbnail

Roche touts near-complete suppression of multiple sclerosis relapse for injectable Ocrevus

Fierce Pharma

One-year data continued to support a more convenient, injectable version of Roche’s blockbuster multiple sclerosis (MS) drug Ocrevus ahead of an FDA decision, the Swiss pharma said. |

FDA 323